Serum levels of coenzyme Q10 in patients with Parkinson's disease

Journal of Neural Transmission

Volumn 107, Issue 2, 2000, Pages 177-181

  Jimenez Jimenez F J ^a,d   Molina, J A ^b   De Bustos, F ^b   Garcia Redondo A ^b   Gomez Escalonilla C ^b   Martinez Salio A ^b   Berbel, A ^b   Camacho, A ^b   Zurdo, M ^a   Barcenilla, B ^a   Enriquez de Salamanca R ^c   Arenas, J ^b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d C/ Corregidor Jose de Pasamonte   (Spain)

Author keywords

Coenzyme Q10; Mitochondrial function; Oxidative stress; Parkinson's disease; Serum levels

Indexed keywords

CHOLESTEROL; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; UBIDECARENONE;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE DURATION; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; ONSET AGE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0033962637     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050015     Document Type: Article

References (11)

1. Ernster L, Dallner G (1995) Biochemical, physiological and medical aspects of ubiquinone function. Ann Neurol 42: 261-264
2. Fahn S, Elton RL, and members of the UPDRS Development Committee (1987) Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson's disease, vol II. McMillan, Florham Park, pp 153-163
3. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427-442
4. Hughes AJ, Ben-Shlomo SE, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson's disease? A clinicopathological study. Neurology 42: 1142-1146
5. Jiménez-Jiménez FJ, Ortǐ-Pareja M, Gasalla-González T (1998a) Epidemiología, etiología y patogenia de la enfermedad de Parkinson. In: Jiménez-Jiménez FJ, Luquin MR, Molina JA (eds) Tratado de los trastornos del movimiento, chap 10. IM&C, Madrid, pp 223-258
6. Jiménez-Jiménez FJ, Ortí-Pareja M, Molina JA (1998b) Alteraciones mitocondriales en las enfermedades neurodegenerativas. In: Jiménez-Jiménez FJ, Molina JA, Arenas J (eds) Enfermedades mitocondriales. Rev Neurol 26 [Suppl 1]: S112-S117
7. 10 in human plasma as a possible marker of oxidative stress. J Lipid Res 37: 67-75
8. 10 level in Parkinson syndrome. In: Folkers K, Littarru GP, Yamagami T (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier Science, Amsterdam, pp 159-166
9. Moreu E, Molinero LM, Fernández E (1990) R-Sigma: Base de datos bioestadística para un ordenador personal. Horus Hardware, Madrid
10. Schapira AHV (1994) Mitochondrial dysfunction in neurodegenerative disorders and aging. In: Schapira AHV, DiMauro S (eds) Mitochondrial disorders in neurology. Butterworth-Heinemann, Oxford, pp 227-244
11. 10 levels correlate with the activities of complexes I and II/III mitochondria from parkinsonian and nonparkinsonian patients. Ann Neurol 42: 261-264